GRP and small cell lung carcinoma: The progastrin-releasing peptide (ProGRP), known for its oncogenic influence in SCLC, is targeted by the monoclonal antibody anti-ProGRP(31-98) D-D3, which has shown selective accumulation in SCLC xenografts within mice.